Saturday 17 October 2026
Export CERT’s income statement to Excel — free account
Certara, Inc.
CERT Healthcare Health Information Services
In the quarter to June 2026, revenue was flat, EPS fell 3,500.0%, free cash flow fell 78.5% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
9.37
0.29
−3.00%
Follow CERT
Certara, Inc. (CERT) P/E ratio
Certara, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 256× (May 2023) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 162× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 175× | (25.40%) |
| 22 more quarters | Free account |
Against its own ten years
Low 0.0×
High 256×
Ten-year median
0.0×
Current reading's percentile
78
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| TDOC Teladoc Health, Inc. compare | n/m |
| SDGR Schrodinger, Inc. compare | n/m |
| CERT Certara, Inc. | n/m |
| OMCL Omnicell, Inc. compare | 41.6× |
| HSTM HealthStream, Inc. compare | 46.0× |
| GDRX GoodRx Holdings, Inc. compare | 62.7× |
| PHR Phreesia, Inc. compare | 64.4× |
| PRVA Privia Health Group, Inc. compare | 102× |
| OMDA Omada Health, Inc. compare | 252× |
| Health Information Services industry median | 39.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)